Skip to main content

Table 1 Findings in 15 patients with ALG8 deficiency

From: ALG8-CDG: novel patients and review of the literature

 

Skladal [11]

Charlwood [14]

Chantret [8]

Schollen [15]

Eklund [9]

Vesela [16]

Stölting [17]

Sorte [18]

Funke [19] Kouwenberg [20]

Patients 1, 2, 5

Sex

F

M

M

F

F

M

M

F

M

F

F

M

M

M

F

Prenatal Data

IUGR

/

/

Yes

/

Yes

No

No

No

No

No

Yes

No

No

No

No

Oligohydramnios

/

/

Yes

/

Yes

No

No

Yes

No

No

No

No

Yes

Yes

No

Hydrops fetalis

/

/

ND

/

/

/

/

Yes

No

No

/

No

Yes

Yes

No

Neonatal data

Weeks of gestation

/

36 w (CS)

35 w (CS)

/

/

35 w

37 w

29 w (CS)

At term

At term

39 w (CS)

35 w

34 w (CS)

35 w (CS)

37 w (CS)

Birth weight

/

2,590 g

2,280 g

/

/

2,920 g

3,070 g

1,420 g

3,980 g

3,680 g

2,210 g

2,920 g

2,570 g

2,700 g

3,080 g

Clinical symptoms

Ascites/edemas

/

 

Yes

Yes

Yes

Yes

Yes

Yes

No

No

Yes

Yes

Yes

Yes

Yes

Onset of first symptoms

From birth

 

From birth

4 months

From birth

8 weeks

From birth

From birth

From birth

From birth

From birth

From birth

From birth

From birth

From birth

Dysmorphism

Yes

 

Yes

No

Yes

Yes

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Gastrointestinal symptoms

/

 

Yes

Yes

No

Yes

Yes

Yes

No

No

Yes

Yes

No

Yes

Yes

Brain involvement

Yes

 

Yes

No

/

Yes

Yes

Yes

Yes

Yes

Yes

Yes

/

Yes

Yes

Hypotonia

/

 

Yes

No

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Skin involvement

/

 

Yes

No

/

Yes

No

No

Yes

Yes

Yes

Yes

No

No

Yes

Eye symptoms

Cataract

 

No

Retinopathy

/

No

Cataract

Optic atrophy

No

No

Nystagmus

No

Cataract

Cataract

Cataract

Laboratory data

               

Thrombocytopenia

/

 

Yes

/

Yes

Yes

Yes

Yes

/

/

Yes

Yes

/

Yes

Yes

Coagulopathy

Yes

 

Yes

Yes

Yes

ND

Yes

Yes

/

/

Yes

Yes

/

Yes

No

Hyponatremia

/

 

Yes

/

Yes

Yes

Yes

/

/

/

/

Yes

Yes

Yes

Yes

Increased transaminases

Yes

 

Yes

No

/

Yes

Yes

No

/

/

Yes

Yes

/

Yes

No

Survival

30 months

4 years

3 months

>3 years

3 days

3 months

16 months

2 months

>6 years

>7 years

8,5 months

3 months

15 min

34 days

39 days

ALG8 mutations

/

Homozygous

Comp. het.

Comp. het.

Comp. het.

Comp. het.

Homozygous

Comp. het.

Comp. het.

Comp. het.

Comp. het.

Comp. het.

/

Comp. het.

Comp. het.

Mutation 1 (genomic)

 

c.139A>C

c.139A>C

c.413delC

c.139A>C

c.673+4A>G

c.139A>C

c.139A>C

c.845C>T

c.845C>T

c.799T>C

c.673+4A>G

 

c.139A>C

c.139A>C

Mutation 1 (functional)

 

p.T47P

p.T47P

p.T138Kfs*19

p.T47P

Splice mutation

p.T47P

p.T47P

p.A282V

p.A282V

p.S267P

Splice mutation

 

p.T47P

p.T47P

Mutation 2 (genomic)

 

c.139A>C

c.96-2A>G

c.396insA

c.96-2A>G

c.824G>A

c.139A>C

c.1090C>T

c.1436delC

c.1436delC

c.808T>C

c.824G>A

 

c.1090C>T

c.1219_1220delCT

Mutation 2 (functional)

 

p.T47P

Splice mutation

p.V133Sfs*3

Splice mutation

p.G275D

p.T47P

p.R364*

p.P479Lfs*6

p.P479Lfs*6

p.F270L

p.G275D

 

p.A364*

p.L407Dfs*23

  1. CS Cesarean section; ND not described or no information available; dysmorphism such as low-set ears, macroglossia, pes equinovarus, campto- and brachydactyly; gastrointestinal symptoms include diarrhea, vomiting, protein-losing enteropathy; CNS defects include structural brain abnormalities, mental or psychomotor retardation, seizures; hypotonia presenting as floppy infant; skin involvement is abnormal fat distribution, wrinkly skin, cutis laxa, inverted nipples; electrolyte disturbances refers to hyponatremia; exitus, death, when written as > years it means age at last follow-up, no further information on outcome, comp. het., compound heterozygous